Office management of patients with diastolic heart failure

CMAJ. Canadian Medical Association Journal

Volumn 180, Issue 5, 2009, Pages 520-527

  Tzanetos, Katina ^a,b   Leong, Derek ^b   Wu, Robert C ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CANDESARTAN; CARVEDILOL; DIGOXIN; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; IRBESARTAN; LISINOPRIL; NEBIVOLOL; NITRIC ACID DERIVATIVE; PERINDOPRIL; PLACEBO; PROPRANOLOL; QUINAPRIL; RAMIPRIL; VERAPAMIL;

AGING; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIASTOLIC HEART FAILURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FOLLOW UP; HEALTH PROGRAM; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MANAGEMENT; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEX DIFFERENCE; SYSTOLIC HEART FAILURE; VITAL SIGN; WALKING;

EID: 62649112111     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.081048     Document Type: Review

References (50)

1. Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol 2006;22:23-45.
2. Gaasch WH, Zile MR. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med 2004;55:373-94.
3. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006;355:260-9.
4. Zile MR, Baicu CF, Bonnema DD. Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis 2005;47:307-13.
5. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002;105:1387-93.
6. Wu EB, Yu CM. Management of diastolic heart failure - a practical review of pathophysiology and treatment trial data. Int J Clin Pract2005;59: 1239-46.
7. Banerjee P, Banerjee T, Khand A, et al. Diastolic heart failure: Neglected or misdiagnosed? J Am Coll Cardiol 2002;39:138-41.
8. Thomas MD, Fox KF, Coats AJ, et al. The epidemiological enigma of heart failure with preserved systolic function. Eur J Heart Fail 2004;6:125-36.
9. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-235.
10. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure. Eur Heart J1998;19:990-1003.
11. Vasan RS, Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101:2118-21.
12. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol1993;22(Suppl A):6A-13A.
13. Owan TE, Redfield MM. Epidemiology of diastolic heart failure. Prog Cardiovasc Dis2005;47:320-32.
14. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997;337:1360-9.
15. Liao L, Jollis JG, Anstrom KJ, et al. Costs for heart failure with normal vs reduced ejection fraction. Arch Intern Med 2006;166:112-8.
16. Vasan RS, Larson MG, Benjamin EJ, et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-55.
17. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA2003;289:194-202.
18. Kitzman DW, Gardin JM, Gottdiener JS, et al.; Cardiovascular Health Study Research Group. Importance of heart failure with preserved systolic function in patients < or = 65 years of age. Cardiovascular Health Study. Am J Cardiol 2001;87:413-9.
19. Devereux RB, Roman MJ, Liu JE, et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 2000;86:1090-6.
20. Kupari M, Lindroos M, Iivanainen AM, et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med1997;241:387-94.
21. Sanderson JE. Heart failure with a normal ejection fraction. Heart2007;93:155-8.
22. Shammas RL, Khan NU, Nekkanti R, et al. Diastolic heart failure and left ventricular diastolic dysfunction: What we know, and what we don't know! Int J Cardiol 2007;115:284-92.
23. Chen HH, Lainchbury JG, Senni M, et al. Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria. J Card Fail 2002;8:279-87.
24. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of dias- tolic heart failure: an epidemiologic perspective. J Am Coll Cardiol1995;26:1565-74.
25. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
26. Senni M, Redfield MM. Heart failure with preserved systolic function. A different natural history? [review]. J Am Coll Cardiol 2001;38:1277-82.
27. Little WC, Brucks S. Therapy for diastolic heart failure. Prog Cardiovasc Dis 2005;47:380-8.
28. Hogg K, McMurray J. The treatment of heart failure with preserved ejection fraction ("diastolic heart failure"). Heart Fail Rev 2006;11:141-6.
29. Massie BM, Fabi MR. Clinical trials in diastolic heart failure. Prog Cardiovasc Dis2005;47:389-95.
30. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. The SAVE Investigators. N Engl J Med1992;327:669-77.
31. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001;357:1385-90.
32. Cleland JG, Tendera M, Adamus J, et al. PEP-CHF I. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J2006;27:2338-45.
33. Zi M, Carmichael N, Lye M. The effect of quinapril on functional status of elderly patients with diastolic heart failure. Cardiovasc Drugs Ther2003;17:133-9.
34. Yip GW, Wang M, Wang T, et al. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 2008;94:573-80.
35. Lang CC, McAlpine HM, Kennedy N, et al. Effects of lisinopril on congestive heart failure in normotensive patients with diastolic dysfunction but intact systolic function. Eur J Clin Pharmacol 1995;49:15-9.
36. Aronow WS, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 1993;71:602-4.
37. Yusuf S, Pfeffer MA, Swedberg K, et al. CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet2003;362:777-81.
38. Flather MD, Shibata MC, Coats AJ, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26:215-25.
39. Aronow WS, Ahn C, Kronzon I. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior my- ocardial infarction, congestive heart failure, and left ventricular ejection fraction < or = 40% treated with diuretics plus angiotensin- converting enzyme inhibitors. Am J Cardiol 1997;80:207-9.
40. Takeda Y, Fukutomi T, Suzuki S, et al. Effects of carvedilol on plasma B-type na- triuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction. Am J Cardiol 2004;94:448-53.
41. Ahmed A, Rich MW, Fleg JL, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 2006;114:397-403.
42. Hung MJ, Cherng WJ, Kuo LT, et al. Effect of verapamil in elderly patients with left ventricular diastolic dysfunction as a cause of congestive heart failure. Int J Clin Pract2002;56:57-62.
43. Cohn JN, Johnson G. Heart failure with normal ejection fraction. The V-HeFT Study. Veterans Administration Cooperative Study Group. Circulation 1990;81(Suppl):III48-53.
44. Ahmed A, Rich MW, Love TE, et al. Digoxin and reduction in mortality and hos- pitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J2006;27:178-86.
45. Gary R. Exercise self-efficacy in older women with diastolic heart failure: results of a walking program and education intervention. J Gerontol Nurs2006;32:31-9; quiz 40-1.
46. Gary RA, Sueta CA, Dougherty M, et al. Home-based exercise improves functional performance and quality of life in women with diastolic heart failure. Heart Lung 2004;33:210-8.
47. Gary R, Lee SY. Physical function and quality of life in older women with dias- tolic heart failure: effects of a progressive walking program on sleep patterns. Prog Cardiovasc Nurs 2007;22:72-80.
48. Smith B, Forkner E, Zaslow B, et al. Disease management produces limited quality- of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients. Am J Manag Care 2005;11:701-13.
49. Galbreath AD. KRS. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation 2004;110:3518-26.
50. Heart Failure Society of America. Educational modules on heart failure. Saint Paul (MN): The Society. Available: www.hfsa.org/hf-modules. asp (accessed 2009 Feb. 2).